The Effect of Sitagliptin on Glucagon Counterregulation and Incretin Hormones During Mild Hypoglycemia in Elderly Patients With Metformin-treated Type 2 Diabetes
Phase of Trial: Phase IV
Latest Information Update: 25 Feb 2019
Price : $35 *
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms SITACLAMP
- 31 Aug 2018 Biomarkers information updated
- 15 Sep 2017 Results presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes.
- 18 May 2017 Status changed from active, no longer recruiting to completed.